Low frequency of the common Norwegian and Finnish LDL-receptor mutations in Swedish patients with familial hypercholesterolaemia

Journal of Internal Medicine

Volumn 244, Issue 1, 1998, Pages 19-25

  Lind, S ^a   Eriksson, M ^a   Rystedt, E ^a   Wiklund, O ^b   Angelin, B ^a   Eggertsen, G ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Familial hypercholesterolaemia; Low density lipoprotein receptor; Mutations

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; HUMAN; MALE; MUTATION RATE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SWEDEN;

ADULT; AGED; EXONS; FEMALE; FINLAND; GENE FREQUENCY; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MUTATION; NORWAY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, LDL; SWEDEN;

EID: 0031877346     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00309.x     Document Type: Article

References (32)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: CR Scriver, AL Beaudet, WS Sly, D Valle, eds The Metabolic and Molecular Basis of Disease, 7th edn. New York: McGraw-Hill Inc., 1995: 1981-2030.
2. Kajinami K, Mabuchi H, Koizumi J, Takeda R. Serum apolipoproteins in heterozygous familial hypercholesterolemia. Clin Chem Acta 1992; 211: 93-9.
3. Hobbs HH, Russell DW, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Ann Rev Genet 1990; 24: 133-70.
4. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Human Mutation 1992; 1: 445-66.
5. Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. New Engl J Med 1987; 317: 734-7.
6. Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH. Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 1990; 85: 1014-23.
7. Kotze MJ, Langenhoven E, Warnich L, Du Plessis L, Marx MP et al. The identification of two low-density lipoprotein receptor gene mutations in South African familial hypercholesterolemia. S Afr Med 1989; 76: 399-401.
8. Aalto-Setälä K, Helve E, Kovanen PT, Kontula K. Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype. J Clin Invest 1989; 84: 499-505.
9. Koivisto U-M, Turtola H, Aalto-Setala K, Top B, Frants RR, Kovanen PT et al. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon ft and is a common cause of FH in Finland. J Clin Invest 1992; 90: 219-28.
10. Koivisto U-M, Vikari JS, Kontula K. Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: Identification of two common missense mutations (Gly823 > Asp and Leu380 > His) and eight rare mutations of the LDL receptor gene. Am J Hum Genet 1995; 57: 789-97.
11. Leren TP, Tonstad S, Gundersen KK, Bakken KS, Rodningen OK, Sunvold H et al. Molecular genetics of familial hypercholesterolaemia in Norway. J Intern Med 1997; 241: 185-94.
12. 66-gly mutations in the LDL-receptor gene: common causes of familial hypercholesterolemia in Denmark. Atherosclerosis 1996; 120: 57-65.
13. Ekström U, Abrahamson M, Sveger T, Lombardi P, Nilsson-Ehle P. An efficient screening procedure detecting six novel mutations in the LDL-receplor gene in Swedish children with hypercholesterolaemia. Hum Genet 1995; 96: 147-50.
14. Wiklund O, Angelin B, Fager G, Eriksson M, Olofsson S-O, Berglund L et al. Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatine or cholestyramine therapy on lipoprotein and apolipoprotein levels. J Intern Med 1990; 228: 241-7.
15. Wiklund O, Angelin B, Olofsson SO, Eriksson M, Fager G, Berglund L et al. Apolipoprotein (a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet 1990; 335: 1360-65.
16. Eggertsen G, Eriksson M, Wiklund O, Ittiä A, Olofsson S-O, Angelin B et al. Time-resolved fluorometry in the genetic diagnosis of familial defective apolipoprotein B-100. J Lipid Res 1994; 35: 1505-8.
17. Gudnason V, Day INM. SSCP analysis and DNA sequencing for genetic characterization of a multi-allelic disorder, familial hypercholesterolemia. In: D. Latchman, ed. PCR Applications in Pathology. Oxford: Oxford University Press, 1994.
18. Koivisto U-M, Hämäläinen L, Taskinen M-R, Kettunen K. Kontula K. Prevalence of familial hypercholesterolemia among young North Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction. J Lipid Res 1995; 34: 267-77.
19. Koivisto PIV, Koivisto U-M, Kovanen PT, Gylling H, Miettinen TA, Kontula K. Deletion of exon 15 of the LDL receptor gene is associated with a mild form of familial hypercholesterolemia. ArteriosclerThromb 1995; 13: 1680-8.
20. Bein G, Gläser R, Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 1992; 39: 68-73.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
22. Leren TP, Solberg K, Rodningen OK, Tonstad S, Ose L. Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemic subjects. Atherosclerosis 1994; 111: 175-82.
23. Day LNM, Whittall R, Haddad L, O'Dell S, Bolia M, Gudnason V et al. Spectrum of LDL receptor mutations in heterozygous familial hypercholesterolemia. Hum Mutat 1997; 10: 116-27.
24. Official Statistics of Sweden. Part III. Distribution by sex, age and citizenship, etc., 1995.
25. Gudnason V, King UL, Seed M, Sun SM, Soutar AK, Humphries SK. Identification of recurrent and novel mutations in exon 4 of the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom. Arterioscler Thromb 1993; 13: 56-63.
26. Hansen PS, Norgaard-Petersen B, Meinertz H, Jensen HK, Hansen AB, Klausen IC et al. Incidence of the apolipoprotein B-3500 mutation in Denmark. Clin Chem Acta 1994; 230: 101-4.
27. Hämäläinen T, Palotie A, Aalto-Setälä K, Kontula K, Tikkanen MJ. Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol. Antherioclerosis 1990; 82: 177-83.
28. Cavalli-Sforza LL, Menozzi P, Piazza P. The History and Geography of Human Genes. Princeton: Princeton University Press, 1994.
29. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Uterman G. Apolipoprotein U polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986; 27: 227-35.
30. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993; 39: 2125-9.
31. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein K polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992; 9: 155-67.
32. Pedersen JC, Berg K. Interaction between low density lipoprotein receptor (LDLR) and apolipoprotein K (apoE) alleles contributes to normal variation in lipid level. Clin Genet 1991; 35: 331-7.